 Your new post is loading...
Your new post is loading...
|
Scooped by
eMedToday
March 2, 2017 8:45 PM
|
The most comprehensive geo-political news service available on the Internet, covering over 263 countries and regions, all U.S. States and Industries.
|
|
Rescooped by
eMedToday
from Pharma & Medical Devices
February 13, 2017 11:33 PM
|
In the fast-moving Washington game of who’s to blame for high U.S. drug prices, an often-overlooked industry is readying its defenses against pharmaceutical companies that fault other parts of the health sector for the costs faced by patients.
Via Richard Meyer
|
|
Rescooped by
eMedToday
from Pharma Hub
February 13, 2017 11:32 PM
|
|
|
Rescooped by
eMedToday
from medical mobile app
January 29, 2017 11:21 PM
|
The Healthcare Industry Can No Longer Ignore Social Media As the healthcare industry continues to constantly change, it is extremely important that healthcare …
Via Marie Ennis-O'Connor, Anna Koczorowska
|
|
Rescooped by
eMedToday
from #eHealthPromotion, #SaluteSocial
January 29, 2017 11:20 PM
|
Constantly evolving social technology and user centric trends make for the perfect digital strategy storm! What platforms are better suited to adapting to drastic changes than those that focus on individualized care? In this article, we highlight the most relevant statistics of social media and healthcare. 1. 42% of individuals viewing health information on social media look at health-related consumer reviews. (Source PWC) Takeaway: Audiences are seeking collective knowledge when it comes to their health related decision making. Having multiple voices who can relate to a similar situation, or who have experienced similar circumstances, will always garner greater persuasion than that of a single brand. 2. 32% of US users post about their friends and family’s health experiences on social media. (Source PWC) Takeaway: Social media platforms like Facebook, Twitter, Google, or even SnapChat have become the modern day blog forums for folks to vent about their loved ones healthcare stories and/or struggles. For healthcare brands and startups, there’s huge potential in connecting with these caregivers and patients.
Via Plus91, Chanfimao, Giuseppe Fattori
As pharma gets ready to explore social media, perhaps they should first ask patients/consumers if they want to engage pharma companies via social media as new research indicates that social media has a very low confidence among US adults. The biggest threat to online health seekers is “trust in information”. There are a lot of sites out there that will automatically cookie users and use those cookies to serve up ads which makes a lot of people uncomfortable. Can pharma leverage social media to enable patient conversations? The answer is yes, but legal people need to stay away from coffee to allow someone at pharma to talk with patients and the FDA has to better understand what patients want from pharma companies via social media. In the course of my research I have learned that nothing is more private than a patients’ health. Using social media to engage pharma companies is a very huge step and pharma has to make sure that the step is worth it by adding value in the patient’s eyes, not marketers. Social media is NOT the answer for pharma at a time when all social media marketing is tanking with stories of false metrics and extremely low organic reach. Social media is part of DTC marketing, but it’s only a very small part of the pie. Further Reading: - “Patients Prefer Easy-to-Find Health Info Over Trusted Health Info”; http://sco.lt/7lCFSj
- “Millennials Trust Pharma Social Media, Mobile Apps & Advertising a Hell of a Lot More Than Their Geezer Parents!”; http://sco.lt/5vrNwH
Via Pharma Guy, Lionel Reichardt / le Pharmageek
|
|
Rescooped by
eMedToday
from Pharma Hub
January 18, 2017 2:52 AM
|
According to Facebook Health industry manager Danielle Salowski, it's the combination of reach, scale, and engagement that make Facebook and Instagram useful tools for healthcare marketers. Facebook reaches 1.7 billion people around the world per month; on mobile, it reaches more than one billion people every day. Similarly, there are 500 million people using Instagram every month and 300 million each day.
Via Plus91, Lionel Reichardt / le Pharmageek, Rémy TESTON, Philippe Marchal
|
|
Scooped by
eMedToday
January 2, 2017 1:02 AM
|
RT @SamBrownInc: Check Out The Year in Digital Health: 2016 Highlights. https://t.co/hSAuAEVRE4 #eHealth #telemedicine #DigitalHealth
|
|
Scooped by
eMedToday
December 27, 2016 9:11 PM
|
Boston Children's Hospital's digital health predictions: reshaping of the patient journey, more patient-centric care, more clinically impactful technology.
|
|
Scooped by
eMedToday
December 21, 2016 1:46 AM
|
Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
|
|
Rescooped by
eMedToday
from Pharma & Medical Devices
December 19, 2016 9:42 PM
|
"You're probably going to see some restraint compared to what we have maybe seen in the last couple of years."
Via Richard Meyer
|
Welcome to the February 28, 2017, edition of Pharma Industry News Update (aka PinUp), which is published every Tuesday and Friday as part of the Pharma Marketing News subscription service. PinUp presents selected content of topical interest from a variety of sources. View the Web version of this issue here: http://bit.ly/PINUP022817 Articles in this issue: Further Reading: About Pharma Industry News Update The Pharma Industry News Update (aka PinUp) is published every Tuesday and Friday as part of the Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources. If you'd like to receive this newsletter, subscribe here.
Via Pharma Guy, Lionel Reichardt / le Pharmageek
While most healthcare stakeholders are eager to embrace digital health, the pharmaceutical sector has been somewhat reluctant to join the digital health bandwagon. Some of the forward-thinking pharma companies are just now awakening to the opportunity for digital health to strengthen their businesses (see “The Pharma Digital Health Accelerator Club”; http://bit.ly/pmn160102iclub). For pharma companies to realize digital health’s potential as quickly as possible, they should seek out and partner with technology startups focused on digital health innovation. Savvy startups should be receptive to these collaborations, as there are major benefits to them from working with pharma. By embracing digital health tools alone or in combination with medications, pharmaceutical companies can: - Improve outcomes
- Build connections to patients
- Strengthen branding
As with many disruptive innovations, digital health requires the development of novel business models and partnerships to succeed. The most effective way for pharmaceutical companies to achieve these benefits is to partner with multiple, compatible digital health startups, and to have these startups build innovative patient and provider-facing digital health solutions on behalf of their pharma partners. When pharma comes courting, a savvy digital health startup should be receptive. It can benefit enormously by working with a drug company. One of the biggest benefits: access to a pharma company’s substantial sales and marketing networks. Selling products into the healthcare system can be extremely difficult because of the wide variety of physician practice models and healthcare procurement processes. Startups often lack the infrastructure needed to reach customers and, therefore, have trouble scaling up sales. Many fail as a result. Teaming with pharma and tapping into their extensive marketing infrastructures and distribution channels will help digital startups gain traction far faster than they could on their own. Which pharmas will embrace partnerships? More…
Via Pharma Guy, Lionel Reichardt / le Pharmageek
|
|
Rescooped by
eMedToday
from Pharma Hub
February 13, 2017 11:31 PM
|
Talk given at the UP College of Pharmacy Emilio T. Yap Auditorium for the UP Pharmaceutical Association, 25 Jan 2017
Via Plus91, Philippe Marchal
The German life sciences company plans to bring its accelerator program for digital health startups to San Francisco. It's now available in Berlin, Moscow, and Shanghai among other places.
Via Lionel Reichardt / le Pharmageek
|
|
Rescooped by
eMedToday
from Pharma & Medical Devices
January 29, 2017 11:21 PM
|
Blockbuster drug sales might be slowing down across the industry.
Via Richard Meyer
|
|
Rescooped by
eMedToday
from Digital marketing pharma
January 23, 2017 2:58 AM
|
Rising demand and associated spending are being fueled by an aging population; the growing prevalence of chronic diseases and comorbidities; development of costly clinical innovations; increasing patient awareness, knowledge, and expectations; and continued economic uncertainty despite regional pockets of recovery are just a few of the key issues and trends impacting the global health care sector. Read on to learn more about trends impacting the global health care sector in 2017 and suggested considerations for stakeholders.
Via Olivier Delannoy
|
|
Rescooped by
eMedToday
from #eHealthPromotion, #SaluteSocial
January 23, 2017 2:57 AM
|
Despite frequent claims to the contrary, social media tools such as Twitter can be incredibly valuable for scholars. My own research (and years of personal experience) has shown that if properly used, Twitter makes it possible for scholars to follow along with cutting-edge research in their discipline as it is presented at conferences on the other side of the world, to directly share their expertise with policy makers and journalists, and to get feedback from expert peers as they work on their own research projects.
New research from the writers of the Fisheries Blog has revealed another professional benefit of social media usage for scholars. “We found that the number of tweets about a primary ecology research article was significantly correlated to the number of citations that the paper received,” said Brandon Peoples, assistant professor of fisheries ecology at Clemson University and the paper’s lead author. This new analysis notes that Twitter activity related to a paper predicted citations more than the 5-year impact factor of the journal where that paper was published, at least for ecology-focused journals.
This PLoS One paper , “Twitter predicts citation rates of ecological research,” is not the first to address this question, and past studies have found mixed results. However, Peoples noted that his new study took a different and more complex approach. “Several studies have looked at the relationship between various altmetrics, measures of activity on, for instance, Facebook, Twitter, or blog posts) and citations. Most of them have used simple bivariate correlations and have found weak relationships,” Peoples said. “What we did differently was account for other important sources of variation in the same model: time since publication, journal impact factor, and random variation among journals. This allowed us to identify the ‘signal’ of Twitter over the ‘noise’ produced by the other variables. You can’t do that with simple correlation analyses.”
Via Pharmacomptoir / Corinne Thuderoz, Giuseppe Fattori
Six of the top 25 largest global pharmaceutical companies announced the formation of Align Biopharma, a new group dedicated to setting technology standards that will make it faster and easier for healthcare professionals (HCPs) to connect with the life sciences industry. Founding members, with input from across the industry, will develop open standards and solutions for companies to streamline how HCPs get the drug and treatment information they need to deliver improved care to patients. In ophthalmology, Allergan and Novartis, the parent company of Alcon, are members of the group. “Common industry standards can make it more effective and efficient for life sciences companies and healthcare professionals to connect,” Patrick Retif, VP IT, Global Commercial at Allergan, said in a news release. “Working together can help harmonize digital engagement and information access across the industry and create a better experience for our shared customers.” The rise of specialty drugs to treat complex diseases is creating a greater need for HCPs to have more timely and tailored information. As the number of new drugs increases so does the amount of information healthcare professionals require to facilitate patient engagement. There is significant potential for biopharmaceutical companies to use digital technology to inform HCPs on new or more complex treatments. Initially, Align Biopharma will focus on developing two new standards to facilitate seamless digital engagement and simplify the HCP experience: Identity management – definition of an identification and authentication standard to enable a single sign-on for HCPs to access online content – including websites, portals, virtual events, or webinars – across all companies. Consent and communication preferences – definition of standards for consent and preference management so that there is consistency in how HCPs specify communication preferences with each company. “Digital is transforming how life sciences companies and HCPs collaborate and interact,” said Paul Shawah, vice president of commercial cloud strategy at Veeva Systems. “With the proliferation of advanced treatments and digital channels, adhering to industry standards will simplify the challenges doctors face in getting the right information quickly.”
Via Pharma Guy, Lionel Reichardt / le Pharmageek
|
|
Rescooped by
eMedToday
from Pharma Hub
January 9, 2017 10:16 PM
|
The battle for the best pharmaceutical marketing practices has begun. And the big guns are now digital pharma marketing gadgets. Social media has slowly but surely bought its place in the pharma marketing budgets, reducing traditional marketing budgets.
Via Plus91, Esposito Christelle, Philippe Marchal
|
|
Rescooped by
eMedToday
from Pharma & Medical Devices
January 2, 2017 12:36 AM
|
The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. Since the beginning of the month, the Office of Prescription Drug Promotion has cited six drugmakers for overstepping their bounds, more than half of its enforcement actions this year.
Via Richard Meyer
|
|
Scooped by
eMedToday
December 27, 2016 9:09 PM
|
A blog about pharmaceutical marketing and advertising written by PharmaGuy, a constructive critic of the industry.
|
|
Scooped by
eMedToday
December 21, 2016 1:46 AM
|
detailed breakup of pharma brands spends by region
|
Scoop.it!
